Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose

Completed

• Conditions: Type 2 Diabetes
• Interventions: Other: fulfill the self-administered questionnaire

• Registration Number: NCT02440555
• Lead Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Brief Summary

Type 2 diabetes is the chronic disease with the most important development in France, and particularly in the Saint-Etienne area due to his specific population.

Different studies showed the interest of screening targeted on high risk population to reduce cardiovascular risks and mortality.

The current screening recommandation is an opportunist targeted screening on population older than 45 years with risk factors by a fasting glucose every 3 years, and a communautaire screening targeted on population older than 45 years suffering precarity with or without risk factors by capillary blood glucose or fasting glucose.

The objective of the Sainté Diabete network is to optimize the screening of diabetics, their follow-up and their treatments. Using a self-administered questionnaire during a medical visit could be a simple, cheap and efficient tool to detect diabetics as soon as possible.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-11
• Primary Completion: 2015-03
• Study Completion: 2015-03
• Study First Submitted: 2015-05-07
• Study First Submitted QC: 2015-05-07
• Study First Posted: 2015-05-12
• Status Verified: 2016-05
• Last Update Submitted: 2016-05-27
• Last Update Posted: 2016-05-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1305

Inclusion Criteria

• Man or woman
• 45 years or older
• Signed informed consent

Exclusion Criteria

• fasting glucose performed in the last 2 years
• diabetes history
• not living in Saint-Etienne

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
patients included	fulfill the self-administered questionnaire	fulfill the self-administered questionnaire.

Primary Outcome Measures

Name	Time	Method
Sensitivity of detection of type 2 diabetes	Day 1 (inclusion day)	To evaluate the sensitivity (true positive) of detection of type 2 diabetes by a self-administered questionnaire performed in a pharmacy or a hospital compared to capillary blood glucose measurements in the same population from the priority health area of Saint-Etienne.

Secondary Outcome Measures

Name	Time	Method
To evaluate the numbers of patients screened by self-administered questionnaire and diagnosed as diabetics using fasting glucose.	Month 2
To evaluate the cost of the targeted screening and the screening accessibility to population from the priority health area of Saint-Etienne	Month 2
Specificity of detection of type 2 diabetes	Day 1 (inclusion day)	To evaluate the specificity (true negative) of detection of type 2 diabetes by a self-administered questionnaire performed in a pharmacy or a hospital compared to capillary blood glucose measurements in the same population from the priority health area of Saint-Etienne

Trial Locations

Locations (1)

Chu Saint-Etienne; 🇫🇷 Saint-etienne, France